XML 23 R14.htm IDEA: XBRL DOCUMENT v3.22.2
Fair Value Measurements and Long-term Investments
6 Months Ended
Jun. 30, 2022
Fair Value Disclosures [Abstract]  
Fair Value Measurements and Long-term Investments

6. Fair Value Measurements and Long-term Investments

Fair value measurements are based upon observable and unobservable inputs.

Level 1: Inputs are unadjusted quoted prices in active markets for identical assets or liabilities at the measurement date.

Level 2: Quoted prices for similar instruments in active markets with inputs that are observable, either directly or indirectly. Our Level 2 derivative financial instruments include foreign currency forward contracts valued based upon observable values of spot and forward foreign currency exchange rates.

Level 3: Unobservable inputs are significant to the fair value of the asset or liability, and include situations where there is little, if any, market activity for the asset or liability. Our Level 3 instrument reflects the fair value of contingent consideration related to a completed acquisition. The fair value is based on a discounted cash flow analysis reflecting the likelihood of achieving specified performance measures or events and captures the contractual nature of the contingencies, commercial risk or time value of money.

The following table summarizes our financial assets and liabilities measured at fair value on a recurring basis as of the respective balance sheet dates:

 

 

Balance Sheet

 

June 30, 2022

 

 

December 31, 2021

 

(In thousands)

 

Classifications

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Foreign exchange
   derivative assets

 

Prepaid expenses
   and other
   current assets

 

$

0

 

 

$

0

 

 

$

0

 

 

$

0

 

 

$

0

 

 

$

352

 

 

$

0

 

 

$

352

 

Total assets

 

 

 

$

0

 

 

$

0

 

 

$

0

 

 

$

0

 

 

$

0

 

 

$

352

 

 

$

0

 

 

$

352

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign exchange
   derivative assets

 

Accrued
  expenses

 

$

0

 

 

$

54

 

 

$

0

 

 

$

54

 

 

$

0

 

 

$

0

 

 

$

0

 

 

$

0

 

Contingent consideration
     - current

 

Accrued
  expenses

 

 

0

 

 

 

0

 

 

 

0

 

 

 

0

 

 

 

0

 

 

 

0

 

 

 

19

 

 

 

19

 

Total liabilities

 

 

 

$

0

 

 

$

54

 

 

$

0

 

 

$

54

 

 

$

0

 

 

$

0

 

 

$

19

 

 

$

19

 

 

The changes in our Level 3 liability measured at fair value on a recurring basis at June 30, 2022 is summarized as follows:

(In thousands)

 

Contingent Consideration

 

Balance at December 31, 2021

 

$

19

 

Payments

 

 

(19

)

Balance at June 30, 2022

 

$

0

 

 

Long-term Investments

The following table summarizes our long-term equity investments which are included in Other assets in the accompanying consolidated balance sheets:

 

 

Number of Investees

 

 

Original

 

 

Carrying Value at

 

(In thousands, except for number of investees)

 

at June 30, 2022

 

 

Cost

 

 

June 30, 2022

 

 

December 31, 2021

 

Equity method investments (1)

 

 

4

 

 

$

7,099

 

 

$

11,579

 

 

$

12,260

 

Cost with adjustments

 

 

7

 

 

 

47,114

 

 

 

49,109

 

 

 

49,293

 

Total long-term equity investments

 

 

11

 

 

$

54,213

 

 

$

60,688

 

 

$

61,553

 

(1) Allscripts share of the earnings of our equity method investees is reported based on a one quarter lag.

 

During the three and six months ended June 30, 2021, one of our third-party cost method investments converted its notes and we received 475 thousand shares in such third party as a result of the conversion. We also revalued our existing investment based on the note conversion share price. The note conversion and the revaluation of the existing investment resulted in a $9.7 million gain, which is included in the Other income, net line in our consolidated statements of operations for the three and six months ended June 30, 2021.

As of June 30, 2022, it is not practicable to estimate the fair value of our non-marketable cost and equity method investments, primarily because of their illiquidity and restricted marketability. The factors we considered in trying to determine fair value include, but are not limited to, available financial information, the issuer’s ability to meet its current obligations, the issuer’s subsequent or planned raises of capital and observable price changes in orderly transactions.

Impairment of Long-term Investments

Each quarter, management performs an assessment of each of our investments on an individual basis to determine if there have been any declines in fair value. Based on our assessment, we determined no impairment charges were necessary for the six months ended June 30, 2022.

Long-term Financial Liabilities

Our long-term financial liabilities include amounts outstanding under our Senior Secured Credit Facility (as described in Note 10, “Debt”), with carrying values that approximate fair value since the interest rates approximate current market rates. Refer to Note 10, “Debt,” for further information regarding our long-term financial liabilities.